Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: Involvement of the mineralocorticoid receptor

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 1, 1996, Pages 73-79

  Sauer, J ^a   Castren, M ^a   Hopfner, U ^a   Holsboer, F ^a   Stalla, G K ^a   Arzt, E ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BACTERIUM LIPOPOLYSACCHARIDE; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MESSENGER RNA; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ADULT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MONOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ALDOSTERONE; BASE SEQUENCE; CELLS, CULTURED; HUMANS; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; MOLECULAR SEQUENCE DATA; MONOCYTES; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER; SIALOGLYCOPROTEINS;

EID: 0030042084     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.1.73     Document Type: Article

References (52)

1. Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK. 1986 There is more than one interleukin 1. Immunol Today. 7:45-56.
2. Dinarello CA. 1992 Role of interleukin-1 in infectious diseases. Immunol Rev. 127:119-146.
3. Arend WP, Joslin FG, Massoni RJ. 1985 Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol. 134:3868-3875.
4. Eisenberg SF, Evans RJ, Arend WP, et al. 1990 Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 343:341-346.
5. Arend WP. 1991 Interleukin 1 receptor antagonist: a new member of the interleukin 1 family. J Clin Invest. 88:1445-1451.
6. Andersson J, Björk L, Dinarello CA, Towbin H, Andersson U. 1992 Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol. 22:2617-2623.
7. Arend WF, Smith MF, Janson RW, Joslin FG. 1991 IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently. J Immunol. 147:1530-1536.
8. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA. 1991 Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood. 78:1275-1281.
9. Besedovsky H, Del Rey A, Sorkin E, Dinarello CA. 1986 Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 233: 652-654.
10. Bateman A, Singh A, Kral T, Solomon S. 1989 The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev. 10:92-112.
11. Gillis S, Crabtree GR, Smith KA. 1979 Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol. 123:1624-1638.
12. Cupps TR, Fauci AS. 1982 Corticosteroid-mediated immunoregulation in man. Immunol Rev. 65:133-155.
13. Snyder DS, Unanue ER. 1982 Corticosteroids inhibit murine macrophage la expression and interleukin 1 production. J Immunol. 129:1803-1805.
14. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. 1986 Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 232:977-980.
15. Lee SW, Tsou A-P, Chan H, Thomas J, Petrie K, Eugui EM. 1988 Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β m RNA. Proc Natl Acad Sci USA. 85:1204-1208.
16. Munck A, Guyre PM, Holbrook NJ. 1984 Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 5:25-44.
17. Carter DB, Deibel MR, Dunn CJ, et al. 1990 Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature. 344:633-638.
18. Mengozzi M, Bertini R, Sironi M, Ghezzi F. 1991 Inhibition by interleukin 1 receptor antagonist of in vivo activities of interleukin 1 in mice. Lymphokine Cytokine Res. 10:405-407.
19. Santos AA, Scheltinga MK, Lynch E, et al. 1993 Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia. Arch Surg. 128:138-144.
20. Arzt E, Sauer J, Pollmächer T, et al. 1994 Glucocorticoids suppress interleukin-I receptor antagonist synthesis following induction by endotoxin. Endocrinology. 134:672-677.
21. Evans RM. 1988 The steroid and thyroid hormone receptor superfamily. Science. 240:889-895.
22. Evans RM, Arriza JL. 1989 A molecular framework for the action of glucocorticoid hormones in the nervous system. Neuron. 2:1105.
23. Arriza JL, Simerly R-B, Swanson LW, Evans RM. 1988 The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron. 1:887-900.
24. Rupprecht R, Arriza JL, Spengler D, et al. 1991 Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol Endocrinol. 7:597-603.
25. Arzt E, Costas M, Finkielman S, Nahmod V. 1991 Serotonin inhibition of TNF-alpha synthesis by human monocytes. Life Sci. 48:2557-2562.
26. Sauer J, Stalla GK, Müller OA, Arzt E. 1994 Inhibition of interleukin-2 mediated lymphocyte activation in patients with Cushing's syndrome: a comparison with hypocortisolemic patients. Neuroendocrinology. 59:144-151.
27. Arzt E, Buric R, Stelzer G, et al. 1993 Interleukin involvement in anterior pituitary cell growth regulation: effects of interleukin-2 (IL-2) and IL-6. Endocrinology. 132:459-467.
28. McColl SR, Paquin R, Ménard C, Beaulieu AD. 1992 Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J Exp Med. 176:593-598.
29. Arzt E, Stelzer C, Renner U, Lange M, Müller OA, Stalla GK. 1992 Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest. 90:1944-1951.
30. Chomczynski P, Sacchi N. 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162: 156-159.
31. Nishida T, Nishino N, Takano M, et al. 1987 cDNA cloning of IL-1α and 1L-1β from mRNA of U937 cells. Biochem Biophys Res Commun. 143:345-352.
32. Arriza JL, Weinberger C, Cerclli G, et al. 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional relationship with the glucocorticoid receptor. Science. 237:268-275.
33. Orino E, Sone S, Nu A, Ogura T. 1942 IL-4 upregulates IL-1 receptor antagonist gene expression and its production in human blood monocytes. J Immunol. 149:925-931.
34. March CJ, Mosley B, Larsen A, et al. 1985 Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature. 315:641-647.
35. Baybutt HN, Holsboer F. 1990 Inhibition of macrophage differentiation and function by cortisol. Endocrinology. 127:476-480.
36. Rupprecht R, Reul JMHM, van Steensel B, et al. 1993 Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur J Pharmacol. 247:145-154.
37. Castrén M, Trapp T, Berninger B, Castrén E, Holsboer F. 1995 Transcriptional induction of rat mineralocorticoid receptor gene in neurons by corticosteroids. J Mol Endocrinol. 74:285-293.
38. McEwen BS, De Kloet ER, Rostene W. 1986 Adrenal steroid receptors and actions in the nervous system. Physiol Rev. 66:1121-1188.
39. De Kloet ER. 1991 Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol. 12:95-164.
40. Siiteri PK, Murai JT, Hammond GL, Nisker JA, Raymore WJ, Kuhm RW. 1982 The serum transport of steroid hormones. Recent Prog Horm Res. 38: 457-463.
41. Umeda T, Hiramatsu R, Iwaoka T, Shimada T, Miura F, Sato T. 1981 Use of saliva for monitoring unbound free cortisol levels in man. Clin Chim Acta. 110:245-253.
42. Miller AH, Spencer RL, Hassett J, et al. 1994 Effects of selective type I and II adrenal steroid agonists on immune cell distribution. Endocrinology. 135: 1934-1944.
43. Schlechte JA, Ginsberg BH, Sherman BM. 1982 Regulation of the glucucorticoid receptor in human lymphocytes. J Steroid Biochem. 16:69-74.
44. Armanini D, Strasser T, Weber PC. 1985 Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am J Physiol. 248:E388-E390.
45. Lowy MT. 1991 Corticosterone regulation of brain and lymphoid corticosteroid receptors. J Steroid Biochem Mol Biol. 39:147-154.
46. Salkowski CA, Vogel SN. 1992 Lipopolysaccharide increases glucocorticoid receptor expression in murine macrophages. J Immunol. 149:4041-4047.
47. Biglieri EG. 1979 Effect of posture on the plasma concentrations of aldosterone in hypertension and primary hyperaldosteronism. Nephron. 23:112-115.
48. 125I-labeled ligand-comparison of three methods. J Clin Endocrinol Metab. 46:105-113.
49. Katz FH, Romfh F, Smith JA. 1975 Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. J Clin Endocrinol Metab. 40:125-130.
50. Miller AH, Spencer RL, Stein M, McEwen BS. 1991 Adrenal steroid receptor binding in spleen and thymus after stress or dexamethasone. Am J Physiol. 259:E405-E412.
51. Spencer RL, Miller AH, Stein M, McEwen BS. 1993 Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptors in neural and immune tissues. Endocrinology. 133:1941-1950.
52. Miller AH, Spencer RL, Husain A, Rhee R, McEwen B, Stein M. 1993 Differential expression of type 1 adrenal steroid receptors in immune tissues is associated with tissue-specific regulation of type II receptors by aldosterone. Endocrinology. 133:2133-2140.